Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Takara Bio stock

4974.T
JP3460200003
A0DNGL

Price

999.00
Today +/-
-0.13
Today %
-2.08 %
P

Takara Bio stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Takara Bio stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Takara Bio stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Takara Bio stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Takara Bio's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Takara Bio Stock Price History

DateTakara Bio Price
11/1/2024999.00 undefined
10/31/20241,020.00 undefined
10/30/20241,020.00 undefined
10/29/20241,001.00 undefined
10/28/2024988.00 undefined
10/25/2024982.00 undefined
10/24/20241,014.00 undefined
10/23/20241,013.00 undefined
10/22/20241,020.00 undefined
10/21/20241,050.00 undefined
10/18/20241,065.00 undefined
10/17/20241,069.00 undefined
10/16/20241,055.00 undefined
10/15/20241,071.00 undefined
10/11/20241,055.00 undefined
10/10/20241,061.00 undefined
10/9/20241,065.00 undefined
10/8/20241,068.00 undefined
10/7/20241,062.00 undefined

Takara Bio Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Takara Bio, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Takara Bio from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Takara Bio’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Takara Bio. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Takara Bio’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Takara Bio’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Takara Bio’s growth potential.

Takara Bio Revenue, EBIT and net profit per share

DateTakara Bio RevenueTakara Bio EBITTakara Bio Net Income
2027e56 B undefined0 undefined5.03 B undefined
2026e51.54 B undefined0 undefined4.32 B undefined
2025e47.92 B undefined0 undefined3.3 B undefined
202443.51 B undefined3 B undefined1.48 B undefined
202378.14 B undefined20.54 B undefined16.01 B undefined
202267.7 B undefined28.9 B undefined19.85 B undefined
202146.09 B undefined13.95 B undefined9.55 B undefined
202034.57 B undefined6.27 B undefined3.82 B undefined
201935.84 B undefined5.46 B undefined3.66 B undefined
201832.31 B undefined3.56 B undefined2.34 B undefined
201729.38 B undefined3.2 B undefined1.35 B undefined
201629.73 B undefined2.67 B undefined1.33 B undefined
201525.97 B undefined2.3 B undefined963 M undefined
201423.91 B undefined1.95 B undefined1.47 B undefined
201320.56 B undefined1.69 B undefined1.46 B undefined
201219.58 B undefined1.55 B undefined1.02 B undefined
201118.74 B undefined1.1 B undefined605 M undefined
201019.33 B undefined557 M undefined591 M undefined
200918.91 B undefined365 M undefined642 M undefined
200820.28 B undefined532 M undefined679 M undefined
200720.98 B undefined-211 M undefined320 M undefined
200616.53 B undefined-1.48 B undefined-1.06 B undefined
200513.69 B undefined-1.08 B undefined-1.28 B undefined

Takara Bio Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
14.3813.5913.6916.5320.9820.2818.9119.3318.7419.5820.5623.9125.9729.7329.3832.3135.8434.5746.0967.778.1443.5147.9251.5456
--5.450.6820.8226.90-3.36-6.732.18-3.044.495.0416.258.6314.48-1.1910.0010.92-3.5633.3346.9015.43-44.3310.147.578.65
44.4648.7646.5343.3046.8150.2652.2251.9552.7253.0453.6152.6053.2454.9157.7157.7357.7261.0669.1672.6957.2961.85---
6.396.636.377.169.8210.199.8810.049.8810.3811.0212.5713.8316.3216.9518.6620.6921.1131.8749.2144.7726.91000
-0.46-0.26-1.08-1.48-0.210.530.370.561.11.551.691.952.32.673.23.565.466.2713.9528.920.543000
-3.19-1.93-7.92-8.97-1.012.621.932.885.887.908.228.178.868.9710.9011.0015.2418.1530.2742.6926.296.90---
-1.140.06-1.28-1.060.320.680.640.590.611.021.461.470.961.331.352.343.663.829.5519.8516.011.483.34.325.03
--104.85-2,430.91-17.47-130.25112.19-5.45-7.942.3769.0942.910.55-34.4938.531.3572.7156.624.43149.99107.91-19.33-90.76122.9730.7616.57
-------------------------
-------------------------
10510594106114113112113113113114118120.42120.42120.42120.42120.42120.42120.42120.42120.42120.42000
-------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Takara Bio Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Takara Bio is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                           
3.126.4913.539.610.8415.9616.4918.4119.0320.4120.7929.9323.8829.1130.0819.5419.0320.2725.9923.6351.8535.42
4.834.614.345.475.75.554.774.644.715.525.956.236.696.797.437.998.569.0512.5917.3412.211.25
000000000000000000046624433
2.622.692.413.943.493.183.293.082.883.093.474.424.645.15.466.016.747.599.1824.0711.0911.85
1.810.550.561.023.660.721.131.110.810.840.941.231.241.1710.980.941.481.352.642.194.21
12.3814.3320.8420.0423.725.4125.6727.2327.4229.8631.1441.8236.4542.1643.9634.5235.2838.3949.1268.1477.5762.76
12.5612.2912.8813.7912.4212.3611.7511.4610.8910.5412.216.9620.5320.5319.5818.5321.424.2129.7736.440.9649.08
1.2921.211.761.590.40.16000000000000.420.480.560
0000000000000000000000
0.610.610.871.721.651.630.930.830.910.840.81.111.161.051.095.95.034.353.222.852.371.54
0.080032.882.811.951.831.51.311.331.481.841.641.218.267.67.016.156.316.676.49
3.142.41.624.143.32.682.642.31.871.481.181.141.451.21.31.461.731.051.52.021.631.39
17.6717.3116.5824.421.8419.8717.4416.4215.1714.1815.5120.6824.9824.4323.1834.1535.7736.6241.0648.0552.1958.49
30.0531.6437.4244.4445.5345.2843.1143.6442.5944.0346.6562.561.4366.5967.1468.6771.0475.0190.17116.19129.76121.25
                                           
13.065.998.748.989.029.049.059.079.079.2314.9714.9714.9714.9714.9714.9714.9714.9714.9714.9714.97
21.6921.7826.3728.2926.926.9526.9726.98272727.1632.8932.8932.8932.8932.8932.8932.8932.8932.8932.8932.89
-1.090.94-0.36-0.581.362.042.362.963.564.585.937.288.149.310.4312.2915.418.527.0945.0157.0553.47
0.03-0.090.030.861.210.7-1.33-1.19-2.02-2.29-0.911.933.542.861.61.710.750.14-0.763.017.3110.18
-1339-9500289109000000000000000
21.6225.7231.9437.3138.453937.1537.837.6138.3641.4257.0759.5460.0159.8961.8564.0166.574.1895.87112.22111.51
1.030.910.751.191.571.221.431.341.171.661.611.551.941.691.941.881.541.032.081.962.321.54
0.240.240.270.250.250.240.260.30.180.170.180.20.190.20.430.330.590.560.740.921.070.96
3.131.421.382.32.52.132.052.181.711.942.112.493.253.483.613.543.894.5310.2414.3610.844.48
12924757444400000188891600000000
00000444545455865490484700134138137151180
4.532.822.463.794.373.643.793.853.13.833.984.375.395.436.035.756.026.2513.1917.3814.387.17
1.621.451.40.590.550.50.460.410.360.340.270.230.180.130.08000.9910.910.820.79
0.450.410.371.430.880.520.360.210.040.090.120.1800.20.2100000.20.180
0.870.820.91.071.131.511.371.371.461.360.810.590.730.730.840.970.931.181.251.161.371.51
2.942.682.663.12.562.542.181.991.861.781.2110.911.051.130.970.932.172.262.272.372.3
7.475.55.126.896.926.185.965.854.975.625.185.376.36.487.166.716.958.4215.4519.6516.759.47
29.0931.2237.0644.245.3745.1743.1143.6442.5743.9846.662.4465.8466.4967.0468.5670.9674.9189.63115.52128.97120.97
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Takara Bio provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Takara Bio's financial health and stability.

Assets

Takara Bio's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Takara Bio must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Takara Bio after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Takara Bio's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-0.950.01-0.89-1.250.380.670.10.70.981.662.272.192.482.912.813.364.825.4313.5527.5321.22
1.181.271.31.481.611.431.51.371.261.21.221.291.481.871.883.063.193.423.714.054.65
000000000000000000000
0.94-0.220.2-0.350.520.420.150.47-0.63-0.88-0.79-0.96-0.72-2.19-2.15-2.81-3.52-3.39-4.04-25.0711.5
1.320.150.540.750.62-0.50.520.640.480.38-0.48-0.260.310.431.040.331.290.870.720.47-0.48
2626201956797477722307242324
0.060.160.110.130.380.220.370.080.580.370.510.760.981.461.591.181.211.251.855.929.9
2.491.221.150.633.132.022.263.172.092.372.232.253.563.023.583.935.786.3413.946.9936.9
-2,336-3,349-2,175-1,986-1,170-1,833-1,053-1,346-1,181-1,011-2,503-5,713-4,891-2,374-1,517-1,592-6,082-4,052-8,845-12,539-5,882
-3.16-1.15-1.32-9.34-0.430.68-5.51-7.06-5.64-0.53-2.08-14.48-3.17-4.1813.49-14.76-5.58-0.21-3.78-7.07-6.69
-0.822.20.85-7.350.742.51-4.46-5.72-4.460.480.42-8.771.72-1.815.01-13.160.513.845.075.47-0.81
000000000000000000000
0.76-0.05-0.254.18-0.04-0.04-0.05-0.08-0.09-0.05-0.06-0.01-0.01-0.04-0.06-0.720-0.1-0.14-0.15-0.15
04.087.480.460.470.09-0.120.030.0300.3211.4000000000
0.594.137.214.60.390.05-0.17-0.06-0.06-00.1511.28-0.23-0.22-0.28-1.21-0.54-0.95-1.1-2.07-4.12
-16995-19-33-3400004101700-2-20-1-100
0000000000-111-123-143-180-216-480-541-841-962-1,923-3,968
-0.084.157.06-3.953.182.71-3.75-3.9-3.771.760.73-0.110.64-1.516.63-12.15-0.5958.85-1.1526.9
153-2,134-1,021-1,3591,9561841,2101,8289101,354-276-3,460-1,3336472,0672,342-3002,2865,096-5,55431,014
000000000000000000000

Takara Bio stock margins

The Takara Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Takara Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Takara Bio.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Takara Bio's sales revenue. A higher gross margin percentage indicates that the Takara Bio retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Takara Bio's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Takara Bio's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Takara Bio's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Takara Bio. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Takara Bio's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Takara Bio Margin History

Takara Bio Gross marginTakara Bio Profit marginTakara Bio EBIT marginTakara Bio Profit margin
2027e61.85 %0 %8.98 %
2026e61.85 %0 %8.37 %
2025e61.85 %0 %6.89 %
202461.85 %6.9 %3.4 %
202357.29 %26.29 %20.49 %
202272.69 %42.69 %29.32 %
202169.16 %30.27 %20.72 %
202061.06 %18.15 %11.05 %
201957.72 %15.24 %10.2 %
201857.73 %11 %7.23 %
201757.71 %10.9 %4.6 %
201654.91 %8.97 %4.49 %
201553.24 %8.86 %3.71 %
201452.6 %8.17 %6.15 %
201353.61 %8.22 %7.11 %
201253.04 %7.9 %5.23 %
201152.72 %5.88 %3.23 %
201051.95 %2.88 %3.06 %
200952.22 %1.93 %3.39 %
200850.26 %2.62 %3.35 %
200746.81 %-1.01 %1.53 %
200643.3 %-8.97 %-6.4 %
200546.53 %-7.92 %-9.37 %

Takara Bio Stock Sales Revenue, EBIT, Earnings per Share

The Takara Bio earnings per share therefore indicates how much revenue Takara Bio has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Takara Bio earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Takara Bio's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Takara Bio’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Takara Bio's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Takara Bio Revenue, EBIT and net profit per share

DateTakara Bio Sales per ShareTakara Bio EBIT per shareTakara Bio Earnings per Share
2027e465.05 undefined0 undefined41.77 undefined
2026e428.04 undefined0 undefined35.84 undefined
2025e397.91 undefined0 undefined27.41 undefined
2024361.29 undefined24.94 undefined12.29 undefined
2023648.94 undefined170.59 undefined132.97 undefined
2022562.21 undefined240.02 undefined164.84 undefined
2021382.73 undefined115.87 undefined79.28 undefined
2020287.05 undefined52.1 undefined31.72 undefined
2019297.65 undefined45.37 undefined30.37 undefined
2018268.34 undefined29.52 undefined19.39 undefined
2017243.95 undefined26.59 undefined11.23 undefined
2016246.89 undefined22.15 undefined11.08 undefined
2015215.66 undefined19.12 undefined8 undefined
2014202.58 undefined16.56 undefined12.46 undefined
2013180.39 undefined14.83 undefined12.82 undefined
2012173.26 undefined13.69 undefined9.05 undefined
2011165.81 undefined9.75 undefined5.35 undefined
2010171.02 undefined4.93 undefined5.23 undefined
2009168.87 undefined3.26 undefined5.73 undefined
2008179.45 undefined4.71 undefined6.01 undefined
2007184.05 undefined-1.85 undefined2.81 undefined
2006155.98 undefined-13.99 undefined-9.98 undefined
2005145.59 undefined-11.53 undefined-13.64 undefined

Takara Bio business model

Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio is one of the most popular companies on Eulerpool.com.

Takara Bio SWOT Analysis

Strengths

Takara Bio Inc possesses several key strengths that contribute to its success in the market. These strengths include:

  • Strong research and development capabilities in the field of biotechnology.
  • Wide range of innovative products and services offered to customers.
  • Strong brand reputation and recognition in the industry.
  • Robust distribution network allowing for efficient market reach.
  • Skilled and knowledgeable workforce committed to excellence.

Weaknesses

Despite its strengths, Takara Bio Inc also faces certain weaknesses that can hinder its growth potential. These weaknesses include:

  • Relatively high dependence on a specific market segment.
  • Limited market share compared to some competitors.
  • Possible vulnerability to changes in regulations and compliance requirements.
  • Lack of strong presence in certain geographic regions.

Opportunities

Takara Bio Inc can capitalize on various opportunities available in the market to further expand and enhance its business. These opportunities include:

  • Increasing demand for biotechnology products and services globally.
  • Exploring new markets and regions with untapped potential.
  • Potential collaborations and partnerships with other industry leaders.
  • Advancements in technology that can drive innovation and product development.
  • Growing focus on personalized medicine and genetic research.

Threats

Takara Bio Inc also faces several threats that pose challenges to its operations and growth. These threats include:

  • Intense competition from established and emerging biotechnology companies.
  • Rapidly changing market trends and customer preferences.
  • Potential disruptions in the supply chain and distribution channels.
  • Increasing regulatory scrutiny and compliance requirements.
  • Economic uncertainties and market fluctuations.

Takara Bio Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Takara Bio historical P/E ratio, EBIT multiple, and P/S ratio

Takara Bio shares outstanding

The number of shares was Takara Bio in 2023 — This indicates how many shares 120.415 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Takara Bio earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Takara Bio's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Takara Bio’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Takara Bio's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Takara Bio stock splits

In Takara Bio's history, there have been no stock splits.

Takara Bio dividend history and estimates

In 2023, Takara Bio paid a dividend amounting to 42 JPY. Dividend means that Takara Bio distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Takara Bio provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Takara Bio’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Takara Bio's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Takara Bio Dividend History

DateTakara Bio Dividend
2027e19.79 undefined
2026e19.78 undefined
2025e19.79 undefined
202417 undefined
202342 undefined
202233 undefined
202116 undefined
20208 undefined
20197 undefined
20184.5 undefined
20174 undefined
20161.8 undefined
20151.5 undefined
20141.2 undefined
20131.1 undefined
20121 undefined

Takara Bio dividend payout ratio

In 2023, Takara Bio had a payout ratio of 21.81%. The payout ratio indicates the percentage of the company's profits that Takara Bio distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Takara Bio represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Takara Bio could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Takara Bio's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Takara Bio Payout Ratio History

DateTakara Bio Payout ratio
2027e20.87 %
2026e21.1 %
2025e20.83 %
202420.67 %
202321.81 %
202220.02 %
202120.18 %
202025.22 %
201923.05 %
201823.21 %
201735.63 %
201616.25 %
201518.76 %
20149.64 %
20138.58 %
201211.04 %
201121.81 %
201021.81 %
200921.81 %
200821.81 %
200721.81 %
200621.81 %
200521.81 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Takara Bio.

Takara Bio latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20237.17 -7.72  (-207.66 %)2024 Q3
9/30/20236.57 6.35  (-3.27 %)2024 Q2
6/30/202313.13 2.65  (-79.82 %)2024 Q1
3/31/20232.02 11.76  (482.18 %)2023 Q4
12/31/202221.51 50.3  (133.81 %)2023 Q3
9/30/202250.8 38.46  (-24.3 %)2023 Q2
6/30/202234.34 32.45  (-5.52 %)2023 Q1
3/31/202249.29 45.55  (-7.58 %)2022 Q4
12/31/202120.5 36.17  (76.41 %)2022 Q3
9/30/202133.23 33.09  (-0.43 %)2022 Q2
1
2

Takara Bio shareholders

%
Name
Stocks
Change
Date
60.91383 % Takara Holdings Inc73,350,00003/31/2024
1.54816 % Nomura Asset Management Co., Ltd.1,864,23212,5009/30/2024
1.13164 % The Vanguard Group, Inc.1,362,67981,6009/30/2024
0.67966 % Nikko Asset Management Co., Ltd.818,4245,3009/30/2024
0.66220 % Daiwa Asset Management Co., Ltd.797,39412,4009/30/2024
0.66171 % BlackRock Institutional Trust Company, N.A.796,8006009/30/2024
0.49885 % Dimensional Fund Advisors, L.P.600,69431,8008/31/2024
0.47252 % Norges Bank Investment Management (NBIM)568,990-187,0106/30/2024
0.41523 % Kyoto Financial Group Inc500,00003/31/2024
0.36067 % Takara Bio Inc. Employees434,300434,3003/31/2024
1
2
3
4
5
...
10

Takara Bio Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
TAKARA HOLDINGS Stock
TAKARA HOLDINGS
SupplierCustomer0,890,920,850,950,930,43
AGC Stock
AGC
SupplierCustomer0,850,630,160,780,42-0,27
MDxHealth Stock
MDxHealth
SupplierCustomer0,190,21-0,340,750,850,49
AnGes Stock
AnGes
SupplierCustomer-0,02-0,28-0,340,290,780,64
BioNTech ADR Stock
BioNTech ADR
SupplierCustomer-0,20-0,810,100,730,740,04
Otsuka Holdings Stock
Otsuka Holdings
SupplierCustomer-0,62-0,49-0,65-0,290,750,67
1

Most common questions regarding Takara Bio

What values and corporate philosophy does Takara Bio represent?

Takara Bio Inc represents values of innovation, dedication, and collaboration in the field of biotechnology. With their corporate philosophy centered on contributing to society through the development of advanced technologies, Takara Bio Inc focuses on improving the quality of life and healthcare. The company aims to create value by delivering cutting-edge solutions and products that cater to diverse research needs, ranging from genetic analysis to regenerative medicine. Takara Bio Inc prioritizes customer satisfaction, sustainability, and responsible business practices, ensuring sustainable growth and development in the biotechnology industry.

In which countries and regions is Takara Bio primarily present?

Takara Bio Inc is primarily present in Japan, with its headquarters located in Kusatsu, Shiga. Apart from its domestic presence, the company also maintains a global presence with operations and subsidiaries in various countries and regions including the United States, Europe, China, and other Asian countries. Takara Bio Inc is a leading biotechnology company specializing in the development and distribution of life science research reagents, gene therapy products, and molecular diagnostics. With its extensive global reach, Takara Bio Inc continues to provide innovative solutions and contribute to advancements in the fields of genomics, stem cell research, and personalized medicine.

What significant milestones has the company Takara Bio achieved?

Takara Bio Inc, a leading biotechnology company, has achieved several significant milestones. They developed and commercialized various innovative products and technologies for life science research, including PCR and DNA sequencing systems. Takara Bio Inc played a pivotal role in advancing genetic engineering and molecular biology techniques worldwide. Additionally, they developed advanced stem cell technologies and contributed to significant breakthroughs in regenerative medicine. Moreover, the company successfully expanded its global presence by establishing subsidiaries and collaborations in various regions. With its continuous commitment to innovation and research, Takara Bio Inc remains at the forefront of the biotechnology industry, providing valuable solutions to researchers and scientists worldwide.

What is the history and background of the company Takara Bio?

Takara Bio Inc is a leading biotechnology company based in Japan. Established in 1967, the company has a rich history and a strong background in the field. Takara Bio specializes in the development and manufacture of a wide range of innovative products and solutions for the life sciences industry. With a focus on advancing research and improving human health, Takara Bio has become synonymous with reliability and cutting-edge technology. Through its dedication to quality and customer satisfaction, the company has gained a global reputation as a trusted provider of biotechnology solutions.

Who are the main competitors of Takara Bio in the market?

The main competitors of Takara Bio Inc in the market are Thermo Fisher Scientific, Bio-Rad Laboratories, and QIAGEN.

In which industries is Takara Bio primarily active?

Takara Bio Inc is primarily active in the life sciences industry. This Japanese company specializes in the development and manufacture of biotechnology products, including genomic research tools, reagents, and systems for areas such as genetic engineering, stem cell research, and diagnostics. Takara Bio Inc's innovative solutions and advanced technologies have made significant contributions to various fields of life sciences, including academic research, pharmaceutical development, and agricultural biotechnology. As a leader in the industry, Takara Bio Inc continuously strives to advance scientific knowledge and provide cutting-edge solutions for the global life sciences community.

What is the business model of Takara Bio?

The business model of Takara Bio Inc revolves around providing innovative biotechnology solutions and products to the global life science industry. Takara Bio Inc primarily focuses on the development and commercialization of technologies related to genetic engineering, biomolecular detection, and amplification, as well as stem cell research. The company offers a wide range of products, including reagents, enzymes, gene editing tools, and other molecular biology tools, catering to the needs of researchers, healthcare professionals, and pharmaceutical companies. Takara Bio Inc aims to contribute to advancements in areas such as personalized medicine, agriculture, and environmental conservation through its cutting-edge biotechnological solutions.

What is the P/E ratio of Takara Bio 2024?

The Takara Bio P/E ratio is 81.28.

What is the P/S ratio of Takara Bio 2024?

The Takara Bio P/S ratio is 2.77.

What is the Quality Investing of Takara Bio?

The Quality Investing for Takara Bio is 4/10.

What is the revenue of Takara Bio 2024?

The Takara Bio revenue is 43.51 B JPY.

How high is the profit of Takara Bio 2024?

The Takara Bio profit is 1.48 B JPY.

What is the business model of Takara Bio

Takara Bio Inc is a leading company in the field of biotechnological research and development. The company specializes in the manufacturing and marketing of high-quality biological reagents and instruments that support a variety of research applications. The business model of Takara Bio Inc is based on providing products and services that assist researchers and scientific laboratories in carrying out their critical workflows. The company offers a wide range of reagents and instruments that focus on various applications such as gene expression, genotyping, proteome analysis, and cell culture. These products are sold worldwide to a variety of customers including pharmaceutical, biotech, and diagnostic companies, as well as public and private research institutions. Takara Bio Inc also has a research and development department that develops new and innovative products to provide solutions to customers and researchers. One such innovation is the SmartChip PCR system, a fully automated instrument that processes multiple samples simultaneously and is used to analyze gene expression profiles on a single chip. Another important area of focus for Takara Bio Inc is the manufacturing of mRNA-based therapeutics, which are used to combat diseases such as cancer. The company has already achieved significant success in this regard and has formed partnerships with other companies and research institutions to further advance. Takara Bio Inc divides its business model into three main divisions. The first division deals with the sale of reagents and instruments for genomic research and cellular analysis. Here, the company offers a wide range of reagents and kits to support DNA purification, PCR products, nanopore sequencing, amplification, genotyping and labeling, as well as plasmid minipreps and RNA isolation. The second division is the therapeutics division, which focuses on mRNA-based therapeutics and customized therapeutic vaccines to keep customers at the forefront of disease fighting in the biotech industry and clinical research. Takara Bio Inc has produced innovative methods for developing vaccines against cancer and other diseases. The third division is the service-oriented application technology, which assists customers in overcoming complex research challenges. The services include customized and technically sophisticated programs such as RNA sequencing, FACS assays, and ChIP sequencing. In summary, Takara Bio Inc is a company that focuses on biotechnological research and development. The business model of Takara Bio Inc includes the manufacturing and marketing of biological reagents and instruments that can be used in both basic research and clinical research and diagnostics. The three main divisions of Takara Bio Inc are the sale of reagents and instruments for genomic research and cellular analysis, the development of mRNA-based therapeutics, and services for customized application programs. With a strong focus on quality and innovation, Takara Bio Inc drives biotechnological research and development and is a leading company in this field.

What is the Takara Bio dividend?

Takara Bio pays a dividend of 33 JPY distributed over payouts per year.

How often does Takara Bio pay dividends?

The dividend cannot currently be calculated for Takara Bio or the company does not pay out a dividend.

What is the Takara Bio ISIN?

The ISIN of Takara Bio is JP3460200003.

What is the Takara Bio WKN?

The WKN of Takara Bio is A0DNGL.

What is the Takara Bio ticker?

The ticker of Takara Bio is 4974.T.

How much dividend does Takara Bio pay?

Over the past 12 months, Takara Bio paid a dividend of 17 JPY . This corresponds to a dividend yield of about 1.7 %. For the coming 12 months, Takara Bio is expected to pay a dividend of 19.79 JPY.

What is the dividend yield of Takara Bio?

The current dividend yield of Takara Bio is 1.7 %.

When does Takara Bio pay dividends?

Takara Bio pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Takara Bio?

Takara Bio paid dividends every year for the past 16 years.

What is the dividend of Takara Bio?

For the upcoming 12 months, dividends amounting to 19.79 JPY are expected. This corresponds to a dividend yield of 1.98 %.

In which sector is Takara Bio located?

Takara Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Takara Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Takara Bio from 6/1/2024 amounting to 17 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Takara Bio pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Takara Bio in the year 2023?

In the year 2023, Takara Bio distributed 42 JPY as dividends.

In which currency does Takara Bio pay out the dividend?

The dividends of Takara Bio are distributed in JPY.

All fundamentals about Takara Bio

Our stock analysis for Takara Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Takara Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.